Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. (September 2015)

• Record Type: Journal Article
• Authors: Mauriello, Claudio; Napolitano, Salvatore; Gambardella, Claudio; Candela, Giancarlo; De Vita, Ferdinando; Orditura, Michele; Sciascia, Valerio; Tartaglia, Ernesto; Lanza, Michele; Santini, Luigi; Conzo, Giovanni
• Is Part Of: International journal of surgery. Volume 21(2015)Supplement 1
• Page Start: S10
• Page End: S14
• Publication Date: 2015-09
• Subjects: Pancreatic neuroendocrine tumors -- Conservative management -- Parenchyma-sparing resections -- Intraoperative ultrasonography -- Thompson procedure; Surgery -- Periodicals; Surgical Procedures, Operative -- Periodicals; 617.005
• DOI: 10.1016/j.ijsu.2015.04.089
• Languages: English
• ISSNs: 1743-9191

Abstract

Abstract: Background: Pancreatic neuroendocrine tumors (pNETs) are uncommon entities. pNETs are often small, slow growing, clinically silent neoplasms. However, they have an almost unpredictable biological behaviour with a not negligible malignant potential. Surgery still represents the treatment of choice, but the high morbidity associated to the enucleation or the formal pancreatectomy should be considered in the decision of the proper treatment. Management of these neoplasms is still debated, and indications for a conservative observational approach and for parenchyma sparing resections are not yet standardized. Method: We review the state of art on the indications for the conservative management of pNETs. Searches on MEDLINE database were performed to identify articles reporting prognostic systems, biochemical screening, observational management, medical treatment and surgical strategies for pNETs. Discussion: Currently, an accurate 'wait-and-see' policy is recommended by the European Neuroendocrine Tumor Society (ENETS) only for non-functioning pNETs (NF-pNETs) <2 cm. A biochemical screening, based on sampling of serum levels of pancreatic polypeptide (PP) and chromogranin A, can address to early conservative surgery for MEN-1 associated NF-pNETs <2 cm to prevent their malignant transformation. The subtotal (80%) distal pancreatectomy first proposed by Thompson, often with the enucleation of possible pancreatic head tumors, still represents a good compromise between oncological radicality and prevention of pancreatic endocrine/exocrine insufficiency caused by standard radical resections for the treatment of inherited syndromes associated with NF-pNETs >2 cm and symptomatic F-pNETs of any size. Conclusion: More studies are needed to further clarify and predict the biologic behaviour of pNETs and increase the indications for conservative observational management and parenchyma sparing pancreas resections.